Since our data in Fig. 6 showed extracellular application of gal-1 can regulate the intracellular pathways for tumor growth, our next question was whether the serum level of gal-1 contributes to the progression of lung adenocarcinoma in human patients? Here, LGALS1 is linked to neoplasm.